Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate von Marder, S.R., Aravagiri, M., Wirshing, W.C., Wirshing, D.A., Lebell, M., Mintz, J.

Volltext

High dose quetiapine in treatment refractory schizophrenia von Pierre, J.M., Wirshing, D.A., Cannell, J., Marks, R., Mendenhall, J., Sheppard, K., Saunders, D.G., Wirshing, W.C.

Volltext

Tolerability of clozapine and risperidone during a twenty nine week trial von Marder, S.R., Schooler, N.R., Kane, J.M., Petrides, G., Chengappa, K.N., Wirshing, W.C., Wirshing, D.A., Umbricht, D., Parapelli, H.

Volltext

Clozapine and risperidone in moderately refractory schizophrenia: A six month double-blind comparison von Schooler, N.R., Marder, S.R., Kane, J.M., Wirshing, W.C., Chengappa, K.N.R., Petrides, G., Wirshing, D.A., McMeniman, M., Parepally, H., Umbricht, D., Baker, R.F.

Volltext

Risperidone vs. haloperidol in treatment-resistant schizophrenia von Wirshing, W.C., Green, M.F., Ames, D., Marshall, B.D., McGurk, S.R., Mintz, J., Marder, S.R.

Volltext

Neurologic deficits, Tardive dyskinesia, and medication status von Ames, D., Wirshing, W.C., Waters, B., Mohgimi, R., Berisford, M.A.

Volltext

The effects of risperidone vs. haloperidol on spatial working memory in treatment-resistant schizophrema von McGurk, S.R., Green, M.F., Wirshing, W.C., Ames, D., Marshall, B.D., Marder, S.R.

Volltext

Risperidone vs. haloperidol in treatment resistant schizophrenia: Preliminary results von Wirshing, W.C., Ames, D., Marder, S.R., Marshall, B.D., Green, M.F., McGurk, S.

Volltext

Risperidone vs. haloperidol: Relative liabilities for OCD and depression von Ames, D., Wirshing, W.C., Marder, S.R., Hwang, S.S., German, C.A., Mintz, J., Goldstein, D.

Volltext

Subjective response to risperidone and haloperidol: Preliminary results von Ames, D., Wirshing, W.C., Marder, S.R., Hwang, S.S., German, C.A., Strough, A.B.

Volltext

Efficacy of clozapine vs. haloperidol in a long-term clinical trial: Preliminary results von Ames, D., Wirshing, W.C., Kane, J., Schooler, N., Marder, S.R., Baker, R., Safferman, A., Ganguli, R., Umbricht, D., Borenstein, M.

Volltext

Plasma level monitoring of depot neuroleptics von Marder, S.R., Van Putten, T., Aravagiri, M., Wirshing, W.C.

Volltext

Adjunctive fluoxetine in haloperidol-stabilized schizophrenics von Ames, D., Wirshing, W.C., Marder, S.R., Yuwiler, A., Brammer, G.L., Midha, K.K., Van Putten, T.

Volltext

Selegiline in the treatment of akathisia, tardive dyskinesia, and negative schizophrenic symptoms von Ames, D., Wirshing, W.C., Lee, M.A., Cummings, J.L., Putten, T.Van, Marder, S.R., Bartzokis, G.

Volltext

Prediction of schizophrenic relapse using prodromal symptoms von Johnston-Cronk, K., Marder, S.R., Wirshing, W.C., Mintz, J., McKenzie, J., Van Putten, T., Lebell, M., Liberman, R.P.

Volltext

Schizophrenic patients' perceptions of relatives and contact: One-year outcome von Lebell, M.B., Marder, S.R., Mintz, J., Mintz, L.I., Wirshing, W.C., Thompson, M., McKenzie, J., Johnston-Cronk, K.

Volltext

Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients von Van Putten, T., Avaragiri, M., Marder, S.R., Wirshing, W.C., Mintz, J., Chabert, N.

Volltext

Management of risk of relapse in schizophrenia von Wirshing, W.C., Marder, S.R., Johnston-Cronk, K., Lebell, M., Mackenzie, J., Mintz, J., Eckman, T., Liberman, R.P.

Volltext